SIX : BSLN.SW

Basilea Pharmaceutica AG — Earnings Estimates

$50.5 CHF

-$0.5 (-0.98%)

Volume
24.96K
Average Volume
23.53K
Market Capitalization
$625.02M
P/E Ratio
19.06
Dividend Yield
0.00%
Price Target
Year High
$59.20
Year Low
$44.70
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$5.11

Annual earnings financials

BSLN.SW financial data with annual/quarterly toggle

BSLN.SW GAAP EPS - Annual & Quarterly

BSLN.SW Sales Revenue - Annual & Quarterly

BSLN.SW Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

BSLN.SW Estimated and Actual Revenue by Quarter
BSLN.SW Estimated and Actual EPS by Quarter
BSLN.SW Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-06-30 1 24.73M 24.73M 24.73M 22.81M 22.81M 22.81M
2026-03-31 1 23.63M 23.63M 23.63M 22.19M 22.19M 22.19M
2025-12-31 1 21.85M 21.85M 21.85M 20.16M 20.16M 20.16M
2025-09-30 1 7M 7M 7M 6.23M 6.23M 6.23M
2025-06-30 1 6.81M 6.81M 6.81M 6.06M 6.06M 6.06M
2023-12-30 6 22.99M 30.52M 24.92M 20.45M 27.15M 22.17M
BSLN.SW Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-06-30 1 40.8M 40.8M 40.8M 25.2M 25.2M 25.2M
2026-03-31 1 - - - 24.51M 24.51M 24.51M
2025-12-31 1 18.84M 18.84M 18.84M 22.27M 22.27M 22.27M
2025-09-30 1 - - - 10.75M 10.75M 10.75M
2025-06-30 1 29.41M 29.41M 29.41M 10.45M 10.45M 10.45M
2023-12-30 6 - - - 35.29M 46.85M 38.24M
BSLN.SW Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-06-30 1 135.81M 135.81M 135.81M 1 3.34272 3.34272 3.34272
2026-03-31 1 132.07M 132.07M 132.07M 0 0 0 0
2025-12-31 1 120M 120M 120M 1 1.54369 1.54369 1.54369
2025-09-30 1 53.45M 53.45M 53.45M 0 0 0 0
2025-06-30 1 51.98M 51.98M 51.98M 1 2.12366 2.12366 2.12366
2023-12-30 6 175.5M 233M 190.21M 0 0 0 0